Mark F. Boshar
Directeur des opérations chez Catamaran Bio, Inc.
Profil
Mark F.
Boshar is currently the Chief Operating Officer at Catamaran Bio, Inc. He previously held various legal and research positions at Genetics Institute LLC, Repligen Corp., Millennium Pharmaceuticals, Inc., Dynogen Pharmaceuticals, Inc., Visterra, Inc., Hale & Dorr LLP, Vitivity, Inc., The Worcester Foundation for Biomedical Research, and Synlogic Operating Co., Inc. He also served as the Vice President-Legal Affairs at Rubius Therapeutics, Inc. from 2017 to 2020.
Boshar received his undergraduate degree from Tufts University and his graduate degree from Northeastern University School of Law.
Postes actifs de Mark F. Boshar
| Sociétés | Poste | Début |
|---|---|---|
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Directeur des opérations | - |
Anciens postes connus de Mark F. Boshar
| Sociétés | Poste | Fin |
|---|---|---|
| RUBIUS THERAPEUTICS | Conseiller Juridique Général | 01/02/2020 |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Conseiller Juridique Général | 01/08/2008 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2003 |
| REPLIGEN CORPORATION | Corporate Officer/Principal | 01/01/1995 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Conseiller Juridique Général | - |
Formation de Mark F. Boshar
| Tufts University | Undergraduate Degree |
| Northeastern University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Entreprise privées | 10 |
|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
| Hale & Dorr LLP | Commercial Services |
| Vitivity, Inc. | |
| The Worcester Foundation for Biomedical Research | |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Finance |
